Panpan Li

180 Fenglin Road
Xuhui, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Ladder Acenes: Staircase-Bending Nanographenes.

Ladder Acenes: Staircase-Bending Nanographenes.

Journal: Organic letters

Published: June 02, 2026

Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis.

Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis.

Journal: Hematological oncology

Published: May 21, 2026

The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma.

The efficacy, safety, and rationale of orelabrutinib combined with obinutuzumab (O2) as a first-line systemic treatment for marginal zone lymphoma.

Journal: Blood cancer journal

Published: March 22, 2026

Dynamic biomarker-based machine learning model predicts short-term treatment response in multiple myeloma.

Dynamic biomarker-based machine learning model predicts short-term treatment response in multiple myeloma.

Journal: Journal of translational medicine

Published: December 06, 2025

Enhancing the Operational Lifetime of OLEDs Through the Modulation of Rigidity and Excited-State Properties.

Enhancing the Operational Lifetime of OLEDs Through the Modulation of Rigidity and Excited-State Properties.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: June 09, 2025

NR5A2 (located on chromosome 1q32) inhibits ferroptosis and promotes drug resistance by regulating phospholipid remodeling in multiple myeloma.

NR5A2 (located on chromosome 1q32) inhibits ferroptosis and promotes drug resistance by regulating phospholipid remodeling in multiple myeloma.

Journal: International journal of biological sciences

Published: March 03, 2025

The role of proliferating stem-like plasma cells in relapsed or refractory multiple myeloma: Insights from single-cell RNA sequencing and proteomic analysis.

The role of proliferating stem-like plasma cells in relapsed or refractory multiple myeloma: Insights from single-cell RNA sequencing and proteomic analysis.

Journal: British journal of haematology

Published: December 01, 2023

Clinical profiles in multiple myeloma patients with extreme survivals: a study from a National Medical Center in China.

Clinical profiles in multiple myeloma patients with extreme survivals: a study from a National Medical Center in China.

Journal: Hematology (Amsterdam, Netherlands)

Published: November 29, 2023

Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma.

Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma.

Journal: International journal of molecular sciences

Published: August 16, 2023

IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m6A-dependent manner.

IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m6A-dependent manner.

Journal: Genes & diseases

Published: July 09, 2023

Zanubrutinib-lenalidomide-rituximab (ZR2) in unfit diffuse large B-cell lymphoma: efficient and tolerant.

Zanubrutinib-lenalidomide-rituximab (ZR2) in unfit diffuse large B-cell lymphoma: efficient and tolerant.

Journal: Annals of hematology

Published: July 05, 2023

Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study.

Update on the outcome of M-protein screening program of multiple myeloma in China: A 7-year cohort study.

Journal: Cancer medicine

Published: June 06, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026